Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sturge-Weber Syndrome × Cannabidiol × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Anxiety Disorders 2 Sturge-Weber Syndrome 1 Solid Tumor 1 Parasomnias 1 Pain 1 Nausea 1 Marijuana Abuse 1 Glioblastoma 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Breast Carcinoma In Situ 1 Arthralgia 1

Interventions

Everolimus 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447846 2023-05-25

Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Phase 2 Completed

11 enrolled 25 charts

Sturge-Weber Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡